Erratum: (Arteriosclerosis, Thrombosis, and Vascular Biology (2013) 33 (2366-2373) DOI: 10.1161/ATVBAHA.113.301221);Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with lewis y on endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 10, 2013, Pages 2366-2373

  Lin, Wei Ling ^a   Chang, Chuan Fa ^a   Shi, Chung Sheng ^a   Shi, Guey Yueh ^a   Wu, Hua Lin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

atherosclerosis; inflammation; leukocytes; Lewis Y antigen; thrombomodulin

Indexed keywords

APOLIPOPROTEIN E; RECOMBINANT THROMBOMODULIN; RECOMBINANT THROMBOMODULIN DOMAIN 1; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; CAROTID ARTERY LIGATION; CELL INFILTRATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHEAR FLOW; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS;

EID: 84885041183     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/01.atv.0000435830.49247.9f     Document Type: Erratum

References (37)

1. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999;340:115-126
2. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504-512
3. Malik AB, Lo SK. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev. 1996;48:213-229
4. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelialdependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res. 2007;101:234-247
5. Dahlbäck B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett. 2005;579:3310-3316
6. Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol. 2012;34:107-125
7. Conway EM, Van De Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogenactivated protein kinase pathways. J Exp Med. 2002;196:565-577
8. Van De Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, Daha MR, Conway EM. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost. 2006;4:1813-1824
9. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, Yamamoto Y, Yamamoto H, Iino S, Taniguchi N, Maruyama I. The N-Terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115:1267-1274
10. Shi CS, Shi GY, Hsiao HM, Hsiao SM, Kao YC, Kuo KL, Ma CY, Kuo CH, Chang BI, Chang CF, Lin CH, Wong CH, Wu HL. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide- induced inflammatory response. Blood. 2008;112:3661-3670
11. Kuo CH, Chen PK, Chang BI, Sung MC, Shi CS, Lee JS, Chang CF, Shi GY, Wu HL. The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen. Blood. 2012;119:1302-1313
12. Westwood JA, Murray WK, Trivett M, et al. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum. J Immunother. 2009;32:292-301
13. Wang C, Yan L, Wang Y, Lin B, Liu S, Li Q, Gao L, Zhang S, Iwamori M. Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β. Anat Rec (Hoboken). 2011;294:961-969
14. Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, Liu J, Zhang S, Iwamori M. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I. J Exp Clin Cancer Res. 2011;30:15
15. Wang ST, Liu JJ, Wang CZ, Lin B, Hao YY, Wang YF, Gao S, Qi Y, Zhang SL, Iwamori M. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma. Oncol Rep. 2012;27:1065-1071
16. Liu J, Lin B, Hao Y, Qi Y, Zhu L, Li F, Liu D, Cong J, Zhang S, Iwamori M. Lewis y antigen promotes the proliferation of ovarian carcinomaderived RMG-I cells through the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2009;28:154
17. Baldus SE, Mönig SP, Zirbes TK, Thakran J, Köthe D, Köppel M, Hanisch FG, Thiele J, Schneider PM, Hölscher AH, Dienes HP. Lewis(y) antigen (CD174) and apoptosis in gastric and colorectal carcinomas: Correlations with clinical and prognostic parameters. Histol Histopathol. 2006;21:503-510
18. Hiraishi K, Suzuki K, Hakomori S, Adachi M. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology. 1993;3:381-390
19. Amin MA, Ruth JH, Haas CS, Pakozdi A, Mansfield PJ, Haghshenas J, Koch AE. H-2g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum. 2008;58:689-695
20. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Bäcker AE, Koch AE. Ley/H: An endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol. 2000;164:4868-4877
21. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, Van Duijnhoven GC, Grabovsky V, Alon R, Figdor CG, van Kooyk Y. DC-SIGNICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol. 2000;1:353-357
22. García-Vallejo JJ, van Liempt E, Da Costa Martins P, Beckers C, van het Hof B, Gringhuis SI, Zwaginga JJ, Van Dijk W, Geijtenbeek TB, van Kooyk Y, Van Die I. DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2. Mol Immunol. 2008;45:2359-2369
23. de Vries T, Knegtel RM, Holmes EH, Macher BA. Fucosyltransferases: Structure/function studies. Glycobiology. 2001;11:119R-128R.
24. Henderson RB, Hobbs JA, Mathies M, Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood. 2003;102:328-335
25. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997;17:2238-2244
26. McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, Hesselbacher SE, Gimple LW, Powers ER, Macdonald T, Sullivan G, Linden J, Sarembock IJ. Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol. 2001;21:791-796
27. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:335-342
28. Braunersreuther V, Mach F. Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? Cell Mol Life Sci. 2006;63:2079-2088
29. Sperandio M, Gleissner CA, Ley K. Glycosylation in immune cell trafficking. Immunol Rev. 2009;230:97-113
30. McEver RP. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J. 1997;14:585-591
31. Bedard PW, Kaila N. Selectin inhibitors: A patent review. Expert Opin Ther Pat. 2010;20:781-793
32. Xie X, Raud J, Hedqvist P, Lindbom L. In vivo rolling and endothelial selectin binding of mononuclear leukocytes is distinct from that of polymorphonuclear cells. Eur J Immunol. 1997;27:2935-2941
33. Becker DJ, Lowe JB. Fucose: Biosynthesis and biological function in mammals. Glycobiology. 2003;13:41R-53R.
34. Homeister JW, Daugherty A, Lowe JB. Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/-mice. Arterioscler Thromb Vasc Biol. 2004;24:1897-1903
35. Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol. 2001;159:797-802
36. Wu KK. Soluble thrombomodulin and coronary heart disease. Curr Opin Lipidol. 2003;14:373-375
37. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study. Lancet. 1999;353:1729-1734